Ovid Therapeutics Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · New York, NY
OVID chart
What traders are saying about $OVID
Latest postsOvid Therapeutics Inc. news
- VC funding in Europe falls short at early-stage investment hurdles
pharmaceutical-technology.com ·
- Ovid Therapeutics at stifel 2026 healthcare conference: two pipeline bets By Investing.com
Investing.com Nigeria ·
- Ovid Therapeutics Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Form S-3 Ovid Therapeutics Inc For: 10 November By Investing.com
Investing.com India ·
- Ovid Therapeutics Reports Q3 Loss of $20.8 Million with GAAP EPS
GuruFocus ·
- Ovid Therapeutics Q3 Results: Loss widens to $(0.10) per share, misses estimates
scanx.trade ·
- Form 8K Ovid Therapeutics Inc For: 10 November By Investing.com
Investing.com India ·
- Ovid Therapeutics Inc. (OVID) Misses Q3 EPS by 1c
StreetInsider ·
- Ovid Therapeutics Reports Q3 2026 Net Loss of $20.8 Million and $161.4 Million in Cash
TradingView ·
- Ovid Therapeutics Q3 net loss widens as R&D spending rises
TradingView ·
- Ovid Therapeutics 3Q 2026: Revenue $0, EPS ($0.1) — 10-Q Summary
TradingView ·
- BRIEF-Ovid Therapeutics Q3 Operating Expenses USD 22.364 Million
TradingView ·
Ovid Therapeutics Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $7.3M | $566,000 | $392,000 | $1.5M |
| Net income | -$17.4M | -$26.4M | -$52.3M | -$54.2M |
| Diluted EPS | – | – | $-0.74 | $-0.77 |
| Total assets (year end) | $150.9M | $92.2M | $144.0M | $155.3M |
| Cash and equivalents (year end) | $13.2M | $26.3M | $27.0M | $44.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Ovid Therapeutics Inc.
- Ticker
- OVID (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, NY
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1636651
Frequently asked questions
What exchange is Ovid Therapeutics Inc. listed on?
Ovid Therapeutics Inc. trades on the Nasdaq under the ticker symbol OVID.
What industry is Ovid Therapeutics Inc. in?
Ovid Therapeutics Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Ovid Therapeutics Inc. headquartered?
Ovid Therapeutics Inc.'s business address on file with the SEC is in New York, NY.
When does Ovid Therapeutics Inc.'s fiscal year end?
Ovid Therapeutics Inc.'s fiscal year ends on December 31.
How much revenue did Ovid Therapeutics Inc. report?
Ovid Therapeutics Inc. reported $7.3M in revenue for calendar year 2025, according to its SEC filings.